Steffie M. B. Peters

Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study

Bastiaan M. Privé, Steffie M. B. Peters, Inge M. van Oort et al. · Clinical Cancer Research · 2021 · 98 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Towards standardization of absolute SPECT/CT quantification: a multi-center and multi-vendor phantom study

Steffie M. B. Peters, Niels R. van der Werf, Marcel Segbers et al. · EJNMMI Physics · 2019 · 95 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome

Steffie M. B. Peters, Bastiaan M. Privé, Maarten de Bakker et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 88 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Variability in lutetium-177 SPECT quantification between different state-of-the-art SPECT/CT systems

Steffie M. B. Peters, Sebastiaan L. Meyer Viol, Niels R. van der Werf et al. · EJNMMI Physics · 2020 · 65 citations · Full text

Medicine, Nuclear Medicine, Radiology +16

[68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatment

Steffie M. B. Peters, Regina Hofferber, Bastiaan M. Privé et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 65 citations · Full text

Medicine, Nuclear Medicine, Oncology +17